pCDNA3.1-nv5-ER beta Citations (3)
Originally described in: Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.Wittmann BM, Sherk A, McDonnell DP Cancer Res. 2007 Oct 1. 67(19):9549-60. PubMed Journal
Articles Citing pCDNA3.1-nv5-ER beta
Articles |
---|
Promyelocytic Leukemia (PML) gene regulation: implication towards curbing oncogenesis. Datta N, Islam S, Chatterjee U, Chatterjee S, Panda CK, Ghosh MK. Cell Death Dis. 2019 Sep 10;10(9):656. doi: 10.1038/s41419-019-1889-2. PubMed |
Overexpression of estrogen receptor GPER1 and G1 treatment reduces SARS-CoV-2 infection in BEAS-2B bronchial cells. Costa AJ, Lemes RMR, Bartolomeo CS, Nunes TA, Pereira GC, Oliveira RB, Gomes AL, Smaili SS, Maciel RMB, Newson L, Ramirez AL, Okuda LH, Prado CM, Stilhano RS, Ureshino RP. Mol Cell Endocrinol. 2022 Dec 1;558:111775. doi: 10.1016/j.mce.2022.111775. Epub 2022 Sep 9. PubMed |
All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells. El Habre R, Aoun R, Tahtouh R, Hilal G. BMC Cancer. 2024 May 21;24(1):615. doi: 10.1186/s12885-024-12379-3. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.